Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases

[1]  D. Boomsma,et al.  Getting personal: Endogenous adenosine receptor signaling in lymphoblastoid cell lines. , 2016, Biochemical pharmacology.

[2]  B. Cronstein,et al.  Regulation of bone and cartilage by adenosine signaling , 2016, Purinergic Signalling.

[3]  D. Veale,et al.  Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis , 2016, Nature Reviews Rheumatology.

[4]  C. Corciulo,et al.  Adenosine A2B receptors play an important role in bone homeostasis , 2016, Purinergic Signalling.

[5]  P. Fishman,et al.  The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis , 2016, Clinical Rheumatology.

[6]  A. Lurati,et al.  The macrophages in rheumatic diseases , 2016, Journal of inflammation research.

[7]  B. Cronstein,et al.  Signaling pathways involving adenosine A2A and A2B receptors in wound healing and fibrosis , 2016, Purinergic Signalling.

[8]  M. Idzko,et al.  Purinergic signaling in scarring , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  E. Cummins,et al.  Adenosine Modulates NR4A Orphan Nuclear Receptors To Attenuate Hyperinflammatory Responses in Monocytic Cells , 2015, The Journal of Immunology.

[10]  H. Kaplan,et al.  A2B adenosine receptor activation switches differentiation of bone marrow cells to a CD11c+Gr‐1+ dendritic cell subset that promotes the Th17 response , 2015, Immunity, inflammation and disease.

[11]  P. Allavena,et al.  Macrophage polarization in pathology , 2015, Cellular and Molecular Life Sciences.

[12]  H. Kaplan,et al.  An A2B Adenosine Receptor Agonist Promotes Th17 Autoimmune Responses in Experimental Autoimmune Uveitis (EAU) via Dendritic Cell Activation , 2015, PloS one.

[13]  D. Crean,et al.  Molecular Interactions between NR4A Orphan Nuclear Receptors and NF-κB Are Required for Appropriate Inflammatory Responses and Immune Cell Homeostasis , 2015, Biomolecules.

[14]  B. A. French,et al.  Adenosine 2B Receptor Activation Reduces Myocardial Reperfusion Injury by Promoting Anti-Inflammatory Macrophages Differentiation via PI3K/Akt Pathway , 2015, Oxidative medicine and cellular longevity.

[15]  P. Fishman,et al.  THU0064 The A3 Adenosine Receptor (A3AR): Therapeutic Target and Predictive Biological Marker in Rheumatoid Arthritis , 2015 .

[16]  F. Liew,et al.  Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis , 2015, Proceedings of the National Academy of Sciences.

[17]  B. Cronstein,et al.  Direct or indirect stimulation of adenosine A2A receptors enhances bone regeneration as well as bone morphogenetic protein‐2 , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  K. Varani,et al.  The A3 Adenosine Receptor: History and Perspectives , 2015, Pharmacological Reviews.

[19]  Z. Szondy,et al.  Adenosine A3 receptors negatively regulate the engulfment-dependent apoptotic cell suppression of inflammation. , 2014, Immunology letters.

[20]  P. Dinarvand,et al.  Adenosine Regulates the Proinflammatory Signaling Function of Thrombin in Endothelial Cells , 2014, Journal of cellular physiology.

[21]  V. Sheffield,et al.  Mechanosensitive release of adenosine 5′‐triphosphate through pannexin channels and mechanosensitive upregulation of pannexin channels in optic nerve head astrocytes: A mechanism for purinergic involvement in chronic strain , 2014, Glia.

[22]  E. Sciaraffia,et al.  Human monocytes respond to extracellular cAMP through A2A and A2B adenosine receptors , 2014, Journal of leukocyte biology.

[23]  R. Schulz,et al.  Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevance. , 2014, Journal of the American College of Cardiology.

[24]  K. J. Muller,et al.  Innexin and pannexin channels and their signaling , 2014, FEBS letters.

[25]  N. Leitinger,et al.  The role of pannexin1 in the induction and resolution of inflammation , 2014, FEBS letters.

[26]  N. Olsen,et al.  Methotrexate induces production of IL-1 and IL-6 in the monocytic cell line U937 , 2014, Arthritis Research & Therapy.

[27]  P. Liu,et al.  Streptococcus suis adenosine synthase functions as an effector in evasion of PMN-mediated innate immunit. , 2014, The Journal of infectious diseases.

[28]  J. Sidaway,et al.  Characterization of the Adenosine Pharmacology of Ticagrelor Reveals Therapeutically Relevant Inhibition of Equilibrative Nucleoside Transporter 1 , 2014, Journal of cardiovascular pharmacology and therapeutics.

[29]  Z. Nemeth,et al.  Adenosine augments IL‐10‐induced STAT3 signaling in M2c macrophages , 2013, Journal of leukocyte biology.

[30]  J. Linden,et al.  Extracellular adenosine regulates naive T cell development and peripheral maintenance , 2013, The Journal of experimental medicine.

[31]  G. Dubyak,et al.  The progressive ankylosis gene product ANK regulates extracellular ATP levels in primary articular chondrocytes , 2013, Arthritis Research & Therapy.

[32]  B. Cronstein,et al.  Adenosine regulates bone metabolism via A1, A2A, and A2B receptors in bone marrow cells from normal humans and patients with multiple myeloma , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  L. A. Alves,et al.  Is pannexin the pore associated with the P2X7 receptor? , 2013, Naunyn-Schmiedeberg's Archives of Pharmacology.

[34]  B. Cronstein,et al.  The Adenosine-Dependent Angiogenic Switch of Macrophages to an M2-Like Phenotype is Independent of Interleukin-4 Receptor Alpha (IL-4Rα) Signaling , 2013, Inflammation.

[35]  K. Varani,et al.  A2A Adenosine Receptors Are Differentially Modulated by Pharmacological Treatments in Rheumatoid Arthritis Patients and Their Stimulation Ameliorates Adjuvant-Induced Arthritis in Rats , 2013, PloS one.

[36]  L. Chiriboga,et al.  Pharmacological blockade of adenosine A2A receptors diminishes scarring , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  N. Olsen,et al.  Methotrexate increases expression of cell cycle checkpoint genes via JNK activation. , 2012, Arthritis and rheumatism.

[38]  B. Cronstein,et al.  The Effect of A2A Adenosine Receptor Activation on C-C Chemokine Receptor 7 Expression in Human THP1 Macrophages During Inflammation , 2012, Inflammation.

[39]  K. Ravid,et al.  A2B Adenosine Receptor Promotes Mesenchymal Stem Cell Differentiation to Osteoblasts and Bone Formation in Vivo* , 2012, The Journal of Biological Chemistry.

[40]  L. Akerman,et al.  Treatment of plaque‐type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[41]  E. Clambey,et al.  Adora2b Adenosine Receptor Engagement Enhances Regulatory T Cell Abundance during Endotoxin-Induced Pulmonary Inflammation , 2012, PloS one.

[42]  B. Cronstein,et al.  Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling , 2012, Purinergic Signalling.

[43]  B. Cronstein,et al.  Adenosine A(2A) receptor ligation inhibits osteoclast formation. , 2012, The American journal of pathology.

[44]  D. Homann,et al.  Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia. , 2011, Antioxidants & redox signaling.

[45]  B. Cronstein.  Adenosine receptors and fibrosis: a translational review , 2011, F1000 biology reports.

[46]  L. Jeong,et al.  Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling. , 2011, Immunobiology.

[47]  A. Chawla,et al.  Involvement of Adenosine A2A Receptors in Engulfment-Dependent Apoptotic Cell Suppression of Inflammation , 2011, The Journal of Immunology.

[48]  Jeffrey M. Wilson,et al.  The A2B Adenosine Receptor Promotes Th17 Differentiation via Stimulation of Dendritic Cell IL-6 , 2011, The Journal of Immunology.

[49]  Yin-Ji Li,et al.  Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis , 2011, Laboratory Investigation.

[50]  B. Fredholm,et al.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update , 2011, Pharmacological Reviews.

[51]  D. J. Schneider,et al.  Distinct Roles for the A2B Adenosine Receptor in Acute and Chronic Stages of Bleomycin-Induced Lung Injury , 2011, The Journal of Immunology.

[52]  B. Cronstein,et al.  Interferon-gamma inhibits adenosine A2A receptor function in hepatic stellate cells by STAT1-mediated repression of adenylyl cyclase. , 2010, International journal of interferon, cytokine and mediator research.

[53]  E. Vizi,et al.  Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation‐induced cell death , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  B. Fredholm,et al.  Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  James N. Moore,et al.  Lipopolysaccharide and TNF-alpha modify adenosine A(2A) receptor expression and function in equine monocytes. , 2010, Veterinary immunology and immunopathology.

[56]  G. Sosinsky,et al.  Pannexin1 and Pannexin2 Channels Show Quaternary Similarities to Connexons and Different Oligomerization Numbers from Each Other* , 2010, The Journal of Biological Chemistry.

[57]  D. Schuppan,et al.  Adenosine: tipping the balance towards hepatic steatosis and fibrosis. , 2010, Journal of hepatology.

[58]  Takashi Nakamura,et al.  Pannexin 3 Regulates Intracellular ATP/cAMP Levels and Promotes Chondrocyte Differentiation* , 2010, The Journal of Biological Chemistry.

[59]  J. Downey,et al.  A2b adenosine receptors can change their spots , 2010, British journal of pharmacology.

[60]  Yuxin Tang,et al.  Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[61]  B. Cronstein,et al.  Methotrexate—how does it really work? , 2010, Nature Reviews Rheumatology.

[62]  L. Belardinelli,et al.  Alterations in Adenosine Metabolism and Signaling in Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis , 2010, PloS one.

[63]  D. J. Schneider,et al.  Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[64]  Dianqing Wu,et al.  Immunopathology and Infectious Diseases Suppression of PLC 2 by Endotoxin Plays a Role in the Adenosine A 2 A Receptor-Mediated Switch of Macrophages from an Inflammatory to an Angiogenic Phenotype , 2010 .

[65]  D. Missiakas,et al.  Staphylococcus aureus synthesizes adenosine to escape host immune responses , 2009, The Journal of experimental medicine.

[66]  K. Varani,et al.  Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate. , 2009, Arthritis and rheumatism.

[67]  R. Biondi,et al.  Inhibition of the Equilibrative Nucleoside Transporter 1 and Activation of A2A Adenosine Receptors by 8-(4-Chlorophenylthio)-modified cAMP Analogs and Their Hydrolytic Products* , 2009, The Journal of Biological Chemistry.

[68]  A. Ohta,et al.  The antihypoxia–adenosinergic pathogenesis as a result of collateral damage by overactive immune cells , 2009, Journal of leukocyte biology.

[69]  M. Sitkovsky,et al.  Differential regulation of HIF‐1α isoforms in murine macrophages by TLR4 and adenosine A2A receptor agonists , 2009, Journal of leukocyte biology.

[70]  A. Douvdevani,et al.  Blocking adenosine A2A receptor reduces peritoneal fibrosis in two independent experimental models. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[71]  R. Berne,et al.  Effects of hypoxia and ischaemia on coronary vascular resistance, A-V node conduction and S-A node excitation. , 2009, Acta medica Scandinavica. Supplementum.

[72]  J. Wilson,et al.  A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence , 2009, Mucosal Immunology.

[73]  L. Chiriboga,et al.  Amendment history : Corrigendum ( April 2009 ) Adenosine signaling contributes to ethanol-induced fatty liver in mice , 2018 .

[74]  M. Sitkovsky.  T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response. , 2009, Trends in immunology.

[75]  Victor H Hernandez,et al.  ATP release through connexin hemichannels and gap junction transfer of second messengers propagate Ca2+ signals across the inner ear , 2008, Proceedings of the National Academy of Sciences.

[76]  E. Vizi,et al.  Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[77]  T. Eckle,et al.  A2B adenosine receptor signaling attenuates acute lung injury by enhancing alveolar fluid clearance in mice. , 2008, The Journal of clinical investigation.

[78]  D. Spray,et al.  P2X7 receptor-Pannexin1 complex: pharmacology and signaling. , 2008, American journal of physiology. Cell physiology.

[79]  B. Cronstein,et al.  Adenosine A2A Receptor Blockade or Deletion Diminishes Fibrocyte Accumulation in the Skin in a Murine Model of Scleroderma, Bleomycin-induced Fibrosis , 2008, Inflammation.

[80]  L. Chiriboga,et al.  Ecto‐5′‐nucleotidase (CD73) ‐mediated extracellular adenosine production plays a critical role in hepatic fibrosis , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[81]  H. Eltzschig,et al.  HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. , 2008, Blood.

[82]  L. Chiriboga,et al.  Pharmacological blockade of A2A receptors prevents dermal fibrosis in a model of elevated tissue adenosine. , 2008, The American journal of pathology.

[83]  Tiejuan Mi,et al.  Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. , 2008, The Journal of clinical investigation.

[84]  J. Ward,et al.  Critical Role of Hypoxia and A2A Adenosine Receptors in Liver Tissue-Protecting Physiological Anti-Inflammatory Pathway , 2008, Molecular medicine.

[85]  W. Junger,et al.  A3 AND P2Y2 RECEPTORS CONTROL THE RECRUITMENT OF NEUTROPHILS TO THE LUNGS IN A MOUSE MODEL OF SEPSIS , 2007, Shock.

[86]  E. Vizi,et al.  A2A adenosine receptors and C/EBPbeta are crucially required for IL-10 production by macrophages exposed to Escherichia coli. , 2007, Blood.

[87]  Linda Yip,et al.  ATP Release Guides Neutrophil Chemotaxis via P2Y2 and A3 Receptors , 2006, Science.

[88]  P. Fishman,et al.  Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression , 2006, Arthritis research & therapy.

[89]  A. Ohta,et al.  A2A adenosine receptor protects tumors from antitumor T cells , 2006, Proceedings of the National Academy of Sciences.

[90]  Hongyan Zhong,et al.  Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. , 2006, The Journal of clinical investigation.

[91]  J. F. Chen,et al.  Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma. , 2006, Arthritis and rheumatism.

[92]  S. Friedman,et al.  Adenosine A2A receptors play a role in the pathogenesis of hepatic cirrhosis , 2006, British journal of pharmacology.

[93]  L. Chibnik,et al.  Dietary caffeine intake does not affect methotrexate efficacy in patients with rheumatoid arthritis. , 2006, The Journal of rheumatology.

[94]  J. G. van der Hoeven,et al.  The effect of adenosine receptor agonists on cytokine release by human mononuclear cells depends on the specific Toll-like receptor subtype used for stimulation. , 2006, Cytokine.

[95]  B. Ma,et al.  Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis. , 2006, The Journal of clinical investigation.

[96]  M. Postow,et al.  Tumor Necrosis Factor-α Prevents Desensitization of Gαs-Coupled Receptors by Regulating GRK2 Association with the Plasma Membrane , 2006, Molecular Pharmacology.

[97]  J. Elias,et al.  Partially adenosine deaminase-deficient mice develop pulmonary fibrosis in association with adenosine elevations. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[98]  E. Vizi,et al.  Adenosine Augments IL-10 Production by Macrophages through an A2B Receptor-Mediated Posttranscriptional Mechanism1 , 2005, The Journal of Immunology.

[99]  Tiejuan Mi,et al.  Adenosine-Dependent Pulmonary Fibrosis in Adenosine Deaminase-Deficient Mice1 , 2005, The Journal of Immunology.

[100]  P. Fishman,et al.  Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models. , 2005, The Journal of rheumatology.

[101]  Courtney M. Lappas,et al.  A2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T Cells1 , 2005, The Journal of Immunology.

[102]  Yizeng Liang,et al.  Simple and rapid determination of adenosine in human synovial fluid with high performance liquid chromatography-mass spectrometry. , 2004, Journal of pharmaceutical and biomedical analysis.

[103]  G. Dahl,et al.  Pannexin membrane channels are mechanosensitive conduits for ATP , 2004, FEBS letters.

[104]  A. Ohta,et al.  Cutting Edge: Physiologic Attenuation of Proinflammatory Transcription by the Gs Protein-Coupled A2A Adenosine Receptor In Vivo , 2004, The Journal of Immunology.

[105]  B. Sperlágh,et al.  Adenosine stimulates CREB activation in macrophages via a p38 MAPK-mediated mechanism. , 2004, Biochemical and biophysical research communications.

[106]  S. Yao,et al.  The equilibrative nucleoside transporter family, SLC29 , 2004, Pflügers Archiv.

[107]  B. Cronstein,et al.  Th1 Cytokines Regulate Adenosine Receptors and Their Downstream Signaling Elements in Human Microvascular Endothelial Cells 1 , 2003, The Journal of Immunology.

[108]  J. Elias,et al.  Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. , 2003, The Journal of clinical investigation.

[109]  S. Vogel,et al.  An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. , 2003, The American journal of pathology.

[110]  A. Tverdal,et al.  Coffee intake and mortality from liver cirrhosis. , 2003, Annals of epidemiology.

[111]  C. Szabó,et al.  The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis. , 2003, European journal of pharmacology.

[112]  G. Nesher,et al.  Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[113]  H. Wong,et al.  The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP‐1 cells , 2002, Journal of leukocyte biology.

[114]  M. Cutolo,et al.  Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines. , 2002, Rheumatology.

[115]  H. Yee,et al.  Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. , 2002, The American journal of pathology.

[116]  B. Cronstein,et al.  Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. , 2002, The American journal of pathology.

[117]  A. Ohta,et al.  Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage , 2001, Nature.

[118]  B. Fredholm,et al.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.

[119]  G. Corrao,et al.  Coffee, caffeine, and the risk of liver cirrhosis. , 2001, Annals of epidemiology.

[120]  B. Cronstein,et al.  Inflammatory Cytokines Regulate Function and Expression of Adenosine A2A Receptors in Human Monocytic THP-1 Cells1 , 2001, The Journal of Immunology.

[121]  D. Ferrari,et al.  Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells , 2001, British journal of pharmacology.

[122]  J. F. Chen,et al.  Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: studies of cells from A2A-receptor-gene-deficient mice. , 2001, The Biochemical journal.

[123]  E. Deitch,et al.  Adenosine inhibits IL-12 and TNF-a production via adenosine A 2 a receptor-dependent and independent mechanisms , 2000 .

[124]  M. Sitkovsky,et al.  A2A receptor dependent and A2A receptor independent effects of extracellular adenosine on murine thymocytes in conditions of adenosine deaminase deficiency , 2000 .

[125]  B. Cronstein,et al.  Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritis. , 2000, Arthritis and rheumatism.

[126]  G. Weissmann,et al.  Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[127]  M. Sitkovsky,et al.  Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. , 1999, Molecular pharmacology.

[128]  T. Shanley,et al.  Suppression of macrophage inflammatory protein (MIP)‐1α production and collagen‐induced arthritis by adenosine receptor agonists , 1998, British journal of pharmacology.

[129]  B. Cronstein,et al.  Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. , 1998, The Journal of clinical investigation.

[130]  Steve Huang,et al.  Memory of Extracellular Adenosine A2A Purinergic Receptor-mediated Signaling in Murine T Cells* , 1997, The Journal of Biological Chemistry.

[131]  D. Knight,et al.  Adenosine A3 receptor stimulation inhibits migration of human eosinophils , 1997, Journal of leukocyte biology.

[132]  K. Messmer,et al.  Effects of adenosine on the functions of circulating polymorphonuclear leukocytes during hyperdynamic endotoxemia , 1997, Infection and immunity.

[133]  C. Edwards,et al.  Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo. , 1997, Cellular and molecular biology.

[134]  E. Vizi,et al.  Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. , 1996, Journal of immunology.

[135]  L. Schook,et al.  Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-alpha. , 1996, European journal of pharmacology.

[136]  B. Fredholm,et al.  Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

[137]  G. Firestein,et al.  Carbohydrate- and CD18-dependent neutrophil adhesion to cardiac myocytes: effects of adenosine. , 1996, Cardiovascular research.

[138]  G. Firestein,et al.  Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors. , 1996, Journal of immunology.

[139]  B. Cronstein,et al.  The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. , 1996, Journal of immunology.

[140]  B. Dijkmans,et al.  Folate supplementation and methotrexate. , 1995, British journal of rheumatology.

[141]  M. Erion,et al.  Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins. , 1995, Journal of immunology.

[142]  G. Corrao,et al.  The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption , 1994, European Journal of Epidemiology.

[143]  G. Alarcón,et al.  Supplementation with Folic Acid during Methotrexate Therapy for Rheumatoid Arthritis: A Double-Blind, Placebo-Controlled Trial , 1994, Annals of Internal Medicine.

[144]  G. Weissmann,et al.  Nonsteroidal antiinflammatory agents inhibit stimulated neutrophil adhesion to endothelium: Adenosine dependent and independent mechanisms , 1994, Inflammation.

[145]  B. Cronstein,et al.  The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. , 1993, The Journal of clinical investigation.

[146]  P. Strong,et al.  Functional characterization of three adenosine receptor types , 1993, British journal of pharmacology.

[147]  A. Klatsky,et al.  Alcohol, Smoking, Cofee, and Cirrhosis , 1992 .

[148]  T. Meshulam,et al.  In vitro, Candida albicans releases the immune modulator adenosine and a second, high-molecular weight agent that blocks neutrophil killing. , 1992, Journal of immunology.

[149]  S. Abramson,et al.  Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. , 1992, Journal of immunology.

[150]  D. Mochly‐Rosen,et al.  The Role of Adenosine and Adenosine Transport in Ethanol‐Induced Cellular Tolerance and Dependence , 1991, Annals of the New York Academy of Sciences.

[151]  T. Steinberg,et al.  Evidence that the gap junction protein connexin-43 is the ATP-induced pore of mouse macrophages. , 1991, The Journal of biological chemistry.

[152]  B. Cronstein,et al.  Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[153]  J. Levick,et al.  Hypoxia and acidosis in chronic inflammatory arthritis; relation to vascular supply and dynamic effusion pressure. , 1990, The Journal of rheumatology.

[154]  B. Cronstein,et al.  The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively. , 1990, The Journal of clinical investigation.

[155]  D. Casso,et al.  Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. , 1990, The Journal of biological chemistry.

[156]  I. Diamond,et al.  Adenosine is required for ethanol-induced heterologous desensitization. , 1989, Molecular pharmacology.

[157]  P. Geborek,et al.  Direct assessment of synovial blood flow and its relation to induced hydrostatic pressure changes. , 1989, Annals of the rheumatic diseases.

[158]  M. Sitkovsky,et al.  Cyclic AMP‐Dependent Protein Kinase as a Part of the Possible Down‐regulating Pathway in the Antigen Receptor‐Regulated Cytotoxic T Lymphocyte Conjugate Formation and Granule Exocytosis , 1988, Annals of the New York Academy of Sciences.

[159]  G. Weissmann,et al.  Adenosine promotes neutrophil chemotaxis , 1988, The Journal of experimental medicine.

[160]  M. Sitkovsky,et al.  Locus of inhibitory action of cAMP-dependent protein kinase in the antigen receptor-triggered cytotoxic T lymphocyte activation pathway. , 1988, The Journal of biological chemistry.

[161]  H. Kofoed.  Synovitis causes hypoxia and acidity in synovial fluid and subchondral bone. , 1986, Injury.

[162]  G. Weissmann,et al.  Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. , 1986, The Journal of clinical investigation.

[163]  S. B. Kramer,et al.  Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. , 1985, Journal of immunology.

[164]  B. Morgan,et al.  2-Chloroadenosine inhibits complement-induced reactive oxygen metabolite production and recovery of human polymorphonuclear leucocytes attacked by complement. , 1985, Biochemical and biophysical research communications.

[165]  S. B. Kramer,et al.  Adenosine: a physiological modulator of superoxide anion generation by human neutrophils , 1983, The Journal of experimental medicine.

[166]  J. Pearson,et al.  The control of adenosine concentration in polymorphonuclear leucocytes, cultured heart cells and isolated perfused heart from the rat. , 1983, The Biochemical journal.

[167]  A. Masi,et al.  Pathogenesis of rheumatoid arthritis: a vascular hypothesis. , 1982, Seminars in arthritis and rheumatism.

[168]  A. Richman,et al.  Reciprocal relationship of synovial fluid volume and oxygen tension. , 1981, Arthritis and rheumatism.

[169]  M. Mehlman,et al.  Mode of action of aspirin. Effect of dietary aspirin on mitochondrial pyruvate metabolism in normal and thiamine-deficient rats. , 1971, The Journal of biological chemistry.

[170]  R. Gubner,et al.  THERAPEUTIC SUPPRESSION OF TISSUE REACTIVITY: II. Effect of Aminopterin in Rheumatoid Arthritis and Psoriasis , 1951, The American journal of the medical sciences.

[171]  A. Szent-Györgyi,et al.  The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart 1 , 1929, The Journal of physiology.

[172]  K. Helle,et al.  History and Perspectives , 2017 .

[173]  N. Olsen,et al.  Methotrexate-mediated inhibition of nuclear factor κB activation by distinct pathways in T cells and fibroblast-like synoviocytes. , 2015, Rheumatology.

[174]  M. Weinblatt.  Methotrexate in rheumatoid arthritis: a quarter century of development. , 2013, Transactions of the American Clinical and Climatological Association.

[175]  R. Jamali,et al.  Synovial fluid adenosine deaminase and high-sensitivity C-reactive protein activity in differentiating monoarthritis , 2010, Rheumatology International.

[176]  B. Cronstein,et al.  Adenosine receptors in wound healing, fibrosis and angiogenesis. , 2009, Handbook of experimental pharmacology.

[177]  P. Fishman,et al.  The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease. , 2009, Cellular immunology.

[178]  V. Strand,et al.  Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial. , 2008, The Journal of rheumatology.

[179]  A. Fanaroff.  The Adenosine System Selectively Inhibits TLR-Mediated TNF-α Production in the Human Newborn , 2007 .

[180]  R. Napieralski,et al.  Evidence for Coordinated Induction and Repression of Ecto-5'-Nucleotidase (CD73) and the A2a Adenosine Receptor in a Human B Cell Line , 2003, Biological chemistry.

[181]  M. Sitkovsky,et al.  Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. , 1997, Blood.

[182]  B. Cronstein,et al.  Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[183]  G. Nyberg.  Effects of adenosine. , 1993, Anesthesia and analgesia.

[184]  A. Klatsky,et al.  Alcohol, smoking, coffee, and cirrhosis. , 1992, American journal of epidemiology.

[185]  D. Mochly‐Rosen,et al.  Chronic ethanol-induced heterologous desensitization is mediated by changes in adenosine transport. , 1990, Biochemical Society symposium.

[186]  G. Alarcón,et al.  The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. , 1990, Arthritis and rheumatism.

[187]  F. Pasini,et al.  Adenosine inhibits polymorphonuclear leukocyte in vitro activation: a possible role as an endogenous calcium entry blocker. , 1985, Journal of immunopharmacology.

[188]  G. Marone,et al.  Adenosine receptors on human inflammatory cells. , 1985, International archives of allergy and applied immunology.

[189]  J. Lindenbaum.  Drugs and vitamin B12 and folate metabolism. , 1983, Current concepts in nutrition.

[190]  A Sattin,et al.  The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices. , 1970, Molecular pharmacology.

[191]  K. H. Lee,et al.  Studies on the mechanism of action of salicylates. IV. Effect of salicylates on oxidative phosphorylation. , 1969, Journal of pharmaceutical sciences.